30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy

      research-article
      a , * , a , b
      Redox Biology
      Elsevier
      ABC, ATP-binding cassette, ABCG2, ATP-binding cassette sub-family G member 2, AIF, apoptosis inducing factor, ALA, aminolevulinic acid, BCC, basal cell carcinoma, BCG, Bacillus Calmette-Guerin, CG, cholangiocarcinoma, CTL, cytotoxic T-lymphocyte, DR4/DR5, TRAIL death receptors, EGF, epithelial growth factor, EMT, epithelial mesenchymal transition, FASL, fas ligand, FDA, food and drug administration, 5-FU, 5-fluorouracil, GI, gastrointestinal, GSNO, S-nitrosoglutathione, HBD, hematoporphyrine-derivative, iNOS, inducible nitric oxide synthase, L-NAME, l-NG-Nitroarginine methyl ester, MAL, methylaminolevulinate, MDR, multidrug resistance, mPEG, monomethoxy-polyethylene glycol, NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells, NK, natural killer, 3O2, molecular singlet oxygen, 1O2, singlet oxygen, PARP, poly ADP ribose polymerase, Pba, pheophorbide a, PDT, photodynamic therapy, PS, photosensitizer, RIPT-1, receptor activity protein I, RKIP, Raf kinase inhibitor protein, ROS, reactive oxygen species, Ru (NO)(NO)(ONO)(pc), nitrosyl-phtalocyanin ruthenium complex, SCC, squamous cell carcinoma, SNAP, S-nitroso-N-acetylpenicillamine, SOD, superoxide dismutase, TNF-α, tumor necrosis factor alpha, TRAIL, TNF-related apoptosis-inducing ligand, TNF-R1/R2, tumor necrosis factor receptor 1/receptor 2, UV, ultraviolet, YY1, Yin Yang 1, Nitric oxide, Photodynamic therapy, Tumor response, Resistance, Molecular pathways.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Photodynamic therapy (PDT) against cancer has gained attention due to the successful outcome in some cancers, particularly those on the skin. However, there have been limitations to PDT applications in deep cancers and, occasionally, PDT treatment resulted in tumor recurrence. A better understanding of the underlying molecular mechanisms of PDT-induced cytotoxicity and cytoprotection should facilitate the development of better approaches to inhibit the cytoprotective effects and also augment PDT-mediated cytotoxicity. PDT treatment results in the induction of iNOS/NO in both the tumor and the microenvironment. The role of NO in cytotoxicity and cytoprotection was examined. The findings revealed that NO mediates its effects by interfering with a dysregulated pro-survival/anti-apoptotic NF-κB/Snail/YY1/RKIP loop which is often expressed in cancer cells. The cytoprotective effect of PDT-induced NO was the result of low levels of NO that activates the pro-survival/anti-apoptotic NF-κB, Snail, and YY1 and inhibits the anti-survival/pro-apoptotic and metastasis suppressor RKIP. In contrast, PDT-induced high levels of NO result in the inhibition of NF-kB, Snail, and YY1 and the induction of RKIP, all of which result in significant anti-tumor cytotoxicity. The direct role of PDT-induced NO effects was corroborated by the use of the NO inhibitor, l-NAME, which reversed the PDT-mediated cytotoxic and cytoprotective effects. In addition, the combination of the NO donor, DETANONOate, and PDT potentiated the PDT-mediated cytotoxic effects. These findings revealed a new mechanism of PDT-induced NO effects and suggested the potential therapeutic application of the combination of NO donors/iNOS inducers and PDT in the treatment of various cancers. In addition, the study suggested that the combination of PDT with subtoxic cytotoxic drugs will result in significant synergy since NO has been shown to be a significant chemo-immunosensitizing agent to apoptosis.

          Graphical abstract

          Highlights

          • PDT-mediated cytotoxic and cytoprotective effects depend also by the induction of NO from tumor.

          • The PDT-induced NO modulates the dysregulated NF-kB/Snail/RKIP loop.

          • The direct role of NO induction by PDT was corroborated by the use of the NO inhibitor, l-NAME.

          • The combination of an NO donor and PDT resulted in a increased cytotoxic effect, in vitro and in vivo.

          • Novel potential therapeutic applications are proposed for the use of PDT combined with NO donors.

          Related collections

          Most cited references86

          • Record: found
          • Abstract: found
          • Article: not found

          The chemical biology of nitric oxide: implications in cellular signaling.

          Nitric oxide (NO) has earned the reputation of being a signaling mediator with many diverse and often opposing biological activities. The diversity in response to this simple diatomic molecule comes from the enormous variety of chemical reactions and biological properties associated with it. In the past few years, the importance of steady-state NO concentrations has emerged as a key determinant of its biological function. Precise cellular responses are differentially regulated by specific NO concentration. We propose five basic distinct concentration levels of NO activity: cGMP-mediated processes ([NO] 400 nM), and nitrosative stress (1 microM). In general, lower NO concentrations promote cell survival and proliferation, whereas higher levels favor cell cycle arrest, apoptosis, and senescence. Free radical interactions will also influence NO signaling. One of the consequences of reactive oxygen species generation is to reduce NO concentrations. This antagonizes the signaling of nitric oxide and in some cases results in converting a cell-cycle arrest profile to a cell survival profile. The resulting reactive nitrogen species that are generated from these reactions can also have biological effects and increase oxidative and nitrosative stress responses. A number of factors determine the formation of NO and its concentration, such as diffusion, consumption, and substrate availability, which are referred to as kinetic determinants for molecular target interactions. These are the chemical and biochemical parameters that shape cellular responses to NO. Herein we discuss signal transduction and the chemical biology of NO in terms of the direct and indirect reactions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Necrotic death as a cell fate.

            Organismal homeostasis depends on an intricate balance between cell death and renewal. Early pathologists recognized that this balance could be disrupted by the extensive damage observed in internal organs during the course of certain diseases. This form of tissue damage was termed "necrosis", derived from the Greek "nekros" for corpse. As it became clear that the essential building block of tissue was the cell, necrosis came to be used to describe pathologic cell death. Until recently, necrotic cell death was believed to result from injuries that caused an irreversible bioenergetic compromise. The cell dying by necrosis has been viewed as a victim of extrinsic events beyond its control. However, recent evidence suggests that a cell can initiate its own demise by necrosis in a manner that initiates both inflammatory and/or reparative responses in the host. By initiating these adaptive responses, programmed cell necrosis may serve to maintain tissue and organismal integrity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A multidrug resistance transporter from human MCF-7 breast cancer cells.

              MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein. RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells. The mRNA encodes a 655-aa [corrected] member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP). Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells. BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                31 July 2015
                December 2015
                31 July 2015
                : 6
                : 311-317
                Affiliations
                [a ]Department of Medical and Biological Sciences, University of Udine, P.le Kolbe 4, 33100 Udine, Italy
                [b ]Department of Microbiology, Immunology and Molecular Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA
                Author notes
                [* ]Corresponding author. Fax: +39 0432 494301. valentina.rapozzi@ 123456uniud.it
                Article
                S2213-2317(15)00087-7
                10.1016/j.redox.2015.07.015
                4556768
                26319434
                12fa8ee7-31e5-43fc-ba12-21855b5b2278
                © 2015 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 19 June 2015
                : 8 July 2015
                : 29 July 2015
                Categories
                Research Paper

                abc, atp-binding cassette,abcg2, atp-binding cassette sub-family g member 2,aif, apoptosis inducing factor,ala, aminolevulinic acid,bcc, basal cell carcinoma,bcg, bacillus calmette-guerin,cg, cholangiocarcinoma,ctl, cytotoxic t-lymphocyte,dr4/dr5, trail death receptors,egf, epithelial growth factor,emt, epithelial mesenchymal transition,fasl, fas ligand,fda, food and drug administration,5-fu, 5-fluorouracil,gi, gastrointestinal,gsno, s-nitrosoglutathione,hbd, hematoporphyrine-derivative,inos, inducible nitric oxide synthase,l-name, l-ng-nitroarginine methyl ester,mal, methylaminolevulinate,mdr, multidrug resistance,mpeg, monomethoxy-polyethylene glycol,nf-kb, nuclear factor kappa-light-chain-enhancer of activated b cells,nk, natural killer,3o2, molecular singlet oxygen,1o2, singlet oxygen,parp, poly adp ribose polymerase,pba, pheophorbide a,pdt, photodynamic therapy,ps, photosensitizer,ript-1, receptor activity protein i,rkip, raf kinase inhibitor protein,ros, reactive oxygen species,ru (no)(no)(ono)(pc), nitrosyl-phtalocyanin ruthenium complex,scc, squamous cell carcinoma,snap, s-nitroso-n-acetylpenicillamine,sod, superoxide dismutase,tnf-α, tumor necrosis factor alpha,trail, tnf-related apoptosis-inducing ligand,tnf-r1/r2, tumor necrosis factor receptor 1/receptor 2,uv, ultraviolet,yy1, yin yang 1,nitric oxide,photodynamic therapy,tumor response,resistance,molecular pathways.

                Comments

                Comment on this article